Tonix Pharmaceuticals

(NASDAQ) TNXP

Current Price$12.10

Market Cap$203.56M

Since IPO (2012)-100%

5 Year-100%

1 Year-56%

1 Month+1%

Tonix Pharmaceuticals Financials at a Glance

Market Cap

$203.56M

Revenue (TTM)

$17.56M

Net Income (TTM)

-$147.39M

EPS (TTM)

-$14.35

P/E Ratio

-0.89

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$12.10

Volume

421,338.169

Open

$12.80

Price

$12.10

Volume

421,338.169

Open

$12.80

Previous Close

$12.77

Daily Range

$12.09 - $13.04

52-Week Range

$11.60 - $69.97

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$12.10

Volume

421,338.169

Open

$12.80

Previous Close

$12.77

Daily Range

$12.09 - $13.04

52-Week Range

$11.60 - $69.97

TNXP News

Page 1

TNXP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tonix Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

142

CEO

Seth Lederman, MD

Website

www.tonixpharma.com

Headquarters

Chatham, NJ 07928, US

TNXP Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

-9%

Net Income Margin

-8%

Return on Equity

-72%

Return on Capital

-66%

Return on Assets

-57%

Earnings Yield

-1.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$203.56M

Shares Outstanding

15.94M

Volume

421.34K

Avg. Volume

431.24K

Financials (TTM)

Gross Profit

$4.54M

Operating Income

-$125.70M

EBITDA

-$123.78M

Operating Cash Flow

-$99.84M

Capital Expenditure

-$3.37M

Free Cash Flow

-$103.21M

Cash & ST Invst.

$207.64M

Total Debt

$1.31M

Tonix Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$6.88M

+183.2%

Gross Profit

$4.75M

+219.3%

Gross Margin

68.99%

N/A

Market Cap

$203.56M

N/A

Market Cap/Employee

$2.51M

N/A

Employees

N/A

Net Income

-$40.19M

-138.8%

EBITDA

-$40.98M

-150.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$184.18M

+40.4%

Accounts Receivable

$8.82M

+82.7%

Inventory

$3.65M

-55.2%

Long Term Debt

$1.13M

+243.9%

Short Term Debt

$162.00K

-31.1%

Return on Assets

-57.15%

N/A

Return on Invested Capital

-66.23%

N/A

Free Cash Flow

-$44.01M

-165.4%

Operating Cash Flow

-$42.32M

-155.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$10.48+4.44%

AVTXAvalo Therapeutics, Inc.

AVTXAvalo Therapeutics, Inc.$15.96-0.37%

NKTXNkarta, Inc.

NKTXNkarta, Inc.$3.25+6.25%

ELDNEledon Pharmaceuticals, Inc.

ELDNEledon Pharmaceuticals, Inc.$3.91+0.39%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.72+0.87%

FATEFate Therapeutics, Inc.

FATEFate Therapeutics, Inc.$2.34+8.60%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.44+2.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ASTCAstrotech

ASTCAstrotech$14.45+4.85%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.33+0.03%

NIONio

NIONio$5.70+0.08%

TET1 Energy Inc.

TET1 Energy Inc.$10.88+0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.81+0.01%

SIDUSidus Space

SIDUSidus Space$6.26+0.01%

NVDANvidia

NVDANvidia$212.37-0.01%

Questions About TNXP

What is the current price of Tonix Pharmaceuticals?

Tonix Pharmaceuticals is trading at $12.14 per share.

What is the 52-week range for Tonix Pharmaceuticals?

Over the past 52 weeks, Tonix Pharmaceuticals has traded between $11.60 and $69.97.

How much debt does Tonix Pharmaceuticals have?

As of the most recent reporting period, Tonix Pharmaceuticals reported total debt of $1.29M.

How much cash does Tonix Pharmaceuticals have on hand?

Tonix Pharmaceuticals reported $185.47M in cash and cash equivalents in its most recent financial results.

What is Tonix Pharmaceuticals’s dividend yield?

Tonix Pharmaceuticals does not currently have a dividend yield.

Tonix Pharmaceuticals

Tonix Pharmaceuticals Financials at a Glance

TNXP News

Why Tonix Pharmaceuticals Continued to Plummet Today

Why Tonix Pharmaceuticals Stock Is Crashing Again Today

Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

Why Tonix Pharmaceuticals Got Crushed Today

Why Tonix Pharmaceuticals Is Down 19% Today

Why Tonix Pharmaceuticals Rocketed 33% Higher Today

Why Tonix Pharmaceuticals Holdings Was a Winner on Wednesday

Why Tonix Pharmaceuticals Is Up by 6% Today

TNXP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tonix Pharmaceuticals

TNXP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tonix Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TNXP

What is the current price of Tonix Pharmaceuticals?

What is the 52-week range for Tonix Pharmaceuticals?

How much debt does Tonix Pharmaceuticals have?

How much cash does Tonix Pharmaceuticals have on hand?

What is Tonix Pharmaceuticals’s dividend yield?

Premium Investing Services